APP and type 1 diabetes mellitus: Transgenic mice expressing both human amylin and APP exhibited exacerbated AD-like pathology compared with mice expressing human APP only or expressing human APP with streptozotocin-induced type 1 diabetes mellitus (T1DM) background [139].